| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2874359 | The Annals of Thoracic Surgery | 2013 | 8 Pages |
Abstract
In the early postoperative period, carperitide has a cardiorenal protective effect that prevents postoperative MACCE and hemodialysis. Perioperative low-dose carperitide infusion may be useful in high-risk patients undergoing on-pump CABG.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Akira MD, PhD, Kin-ichi MD, PhD, Mitsuru MD, PhD, Isamu MD, PhD, Shinji MD, PhD, Hirokaki MD, PhD, Motomi MD, PhD,